Nucleoside & Nucleotide Modification Service
Biological Significance of Modification of Nucleoside & Nucleotide
Modification of nucleosides and nucleotides is pivotal in the functional regulation of cells and life activities. The function of DNA and RNA can be modulated by changing their structure and introducing different chemical groups. Such modifications are essential to the process of drug discovery and development. For example, by targeting specific nucleotide modifications, researchers can design drugs with specific biological activities to inhibit the growth of pathogens or treat certain genetic diseases. Modifications such as glycosylation, phosphorylation, and acetylation can change nucleotide molecule charge state and structure thus impacting signaling pathways The techniques of nucleotide modification can also be used for gene editing. By modifying nucleotide molecules, researchers can design and develop nucleic acid sequences with specific functions for editing or repairing a patient's genes, which is important for several inherited diseases.
Key Technologies
At CD BioGlyco, our nucleoside & nucleotide modification service leverages advanced chemical and chemoenzymatic synthesis technologies to perform precise base modifications (e.g., halogenation, conjugation), sugar moiety alterations (methylation, phosphorylation), phosphate group engineering, and specialized labeling (fluorescent, isotopic, radionuclide). We utilize our Glyco™ synthesis platform to deliver custom modifications that enhance functionality for drug discovery, biosensors, and gene editing applications.
Nucleoside & Nucleotide Modification Service at CD BioGlyco
CD BioGlyco has a comprehensive and state-of-the-art Glyco™ Synthesis Platform that integrates the latest synthetic methods, processes, and equipment to provide you with efficient and reliable modification services. Some of the Nucleoside & Nucleotide modifications we provide are as follows:
Base-based Modification Service
CD BioGlyco provides base-based nucleoside & nucleotide modification services. Our efficient workflow and strict quality management system ensure the on-time delivery of projects and help our clients achieve success in drug discovery.
Suger-based Modification Service
CD BioGlyco specializes in providing top-notch sugar-based modification services and customized solutions for your needs. Our sugar-based modification technologies cover a wide range of modification types, including methylation, phosphorylation, modification, etc.
Phosphate Group-based Modification Service
CD BioGlyco provides phosphate group-based nucleotide modification services on biological macromolecules using state-of-the-art chemistry to provide you with the highest quality customized modification solutions.
Fluorescent Labeling Modification Service
CD BioGlyco specializes in nucleotides & nucleotide modification services. We use the most advanced technology and high-quality fluorescent dyes for labeling to ensure that the labeled nucleotides have good fluorescence intensity and stability.
Stable Isotope Labeling Modification Service
Our professional team has extensive experience in providing high-quality isotope labeling solutions, customized to clients' specific requirements, based on our deep expertise and technical strength.
Radionuclide Labeling Modification Service
CD BioGlyco has many years of experience and technical capabilities in radionuclide labeling modification of nucleosides & nucleotides. We recognize the different needs of different research fields, thus we offer customized services to each client uniquely.
Workflow
Our modification service follows a meticulous, multi-step workflow to ensure the successful and efficient synthesis of custom-modified nucleosides and nucleotides.
- Consultation and Design
Our expert team collaborates with you to define the exact modification, target molecule, and application. We review the synthesis feasibility and provide a detailed project plan and quote.
- Synthetic Pathway Development
Based on your requirements, we design or optimize a synthetic route. This involves selecting the appropriate starting materials, reagents, and reaction conditions to achieve the desired modification with high yield and purity.
- Synthesis and Purification
Our skilled chemists execute the multi-step synthesis. Each step is monitored to ensure high conversion and minimize side reactions. The crude product is then rigorously purified using advanced techniques like HPLC to isolate the target modified nucleoside or nucleotide.
- Derivatization and Quality Control
The purified modified nucleoside or nucleotide can be further derivatized into a phosphoramidite for solid-phase oligonucleotide synthesis or into a triphosphate for enzymatic applications. The final product is subjected to comprehensive quality control using mass spectrometry, NMR, and HPLC to confirm its structure and purity.
Publication Data
DOI.: 10.3389/fchem.2022.1051525
Journal: Frontiers in Chemistry
Published: 2022
IF: 4.2
Results: This review explores the applications of nucleobase-modified nucleosides and nucleotides—analogs lacking conventional hydrogen-bonding groups. The author details their use as mechanistic probes to study DNA polymerase activity and fidelity, revealing that hydrogen bonding is not essential for replication and highlighting roles for desolvation, shape complementarity, and π-stacking. The article further discusses their application in synthetic biology for expanding the genetic code beyond natural base pairs (e.g., Ds:Px pair) and creating novel aptamers. Finally, it covers their therapeutic potential, particularly in cancer treatment, where analogs like 5-nitroindole derivatives can inhibit translesion DNA synthesis (TLS) and enhance the efficacy of DNA-damaging agents like temozolomide.
Applications
- By chemically modifying nucleotides, drugs with specific biological activities can be designed and developed.
- Modified nucleotides can be used in drug discovery, including the development of drugs, vaccines, and antibodies that target specific genes or proteins.
- Modified nucleotides can be used to construct biosensors for the detection of various biomolecules, chemicals, or pollutants in the environment.
Advantages of Us
- We offer many different modification methods to provide our clients with more possibilities for their research.
- Our highly flexible synthetic strategies allow us to design optimal synthetic pathways for complex chemical structures and ensure high yields and purity of the synthesized products
- We utilize state-of-the-art technical equipment and stringent quality management processes to ensure that our services operate at a high standard.
Frequently Asked Questions
Associated Services
Our nucleoside & nucleotide modification enables precise tailoring of molecular properties (e.g., stability, targeting) for therapeutic or diagnostic research. To support these advanced modifications, we provide comprehensive precursor and quality control services:
- Nucleoside Chemical Synthesis Service
- Nucleoside Enzymatic Synthesis Service
- Nucleoside Cell Factory Synthesis Service
- Nucleotide Chemical Synthesis Service
- Nucleotide Microbial Synthesis Service
- Nucleotide Enzymatic Digestion Service
CD BioGlyco adopts a variety of advanced chemical and chemoenzymatic synthesis techniques to provide custom Nucleoside & Nucleotide modification services for clients around the world. If you need Nucleoside & Nucleotide modification services, please feel free to contact us for more detailed information.
Reference
- Berdis, A. Nucleobase-modified nucleosides and nucleotides: applications in biochemistry, synthetic biology, and drug discovery. Frontiers in Chemistry. 2022, 10: 1051525. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




